Page last updated: 2024-10-31

mitoxantrone and Depressive Disorder, Major

mitoxantrone has been researched along with Depressive Disorder, Major in 1 studies

Mitoxantrone: An anthracenedione-derived antineoplastic agent.
mitoxantrone : A dihydroxyanthraquinone that is 1,4-dihydroxy-9,10-anthraquinone which is substituted by 6-hydroxy-1,4-diazahexyl groups at positions 5 and 8.

Depressive Disorder, Major: Disorder in which five (or more) of the following symptoms have been present during the same 2-week period and represent a change from previous functioning; at least one of the symptoms is either (1) depressed mood or (2) loss of interest or pleasure. Symptoms include: depressed mood most of the day, nearly every daily; markedly diminished interest or pleasure in activities most of the day, nearly every day; significant weight loss when not dieting or weight gain; Insomnia or hypersomnia nearly every day; psychomotor agitation or retardation nearly every day; fatigue or loss of energy nearly every day; feelings of worthlessness or excessive or inappropriate guilt; diminished ability to think or concentrate, or indecisiveness, nearly every day; or recurrent thoughts of death, recurrent suicidal ideation without a specific plan, or a suicide attempt. (DSM-5)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Duprat, R1
Desmyter, S1
Rudi, de R1
van Heeringen, K1
Van den Abbeele, D1
Tandt, H1
Bakic, J1
Pourtois, G1
Dedoncker, J1
Vervaet, M1
Van Autreve, S1
Lemmens, GM1
Baeken, C1

Clinical Trials (3)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Establishing Functional Biomarkers for Spaced Theta-Burst Stimulation[NCT03687892]37 participants (Actual)Interventional2019-04-01Terminated (stopped due to Change in study personnel.)
Accelerated Theta Burst in Chronic Pain: A Biomarker Study[NCT03984201]60 participants (Anticipated)Interventional2023-06-30Not yet recruiting
Using Multiple Brain-based Biomarkers to Validate and Predict Response to Theta Burst Stimulation as a New Treatment for Major Depressive Disorder[NCT03626181]30 participants (Anticipated)Interventional2018-07-06Recruiting
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trials

1 trial available for mitoxantrone and Depressive Disorder, Major

ArticleYear
Accelerated intermittent theta burst stimulation treatment in medication-resistant major depression: A fast road to remission?
    Journal of affective disorders, 2016, Volume: 200

    Topics: Adult; Age Factors; Antineoplastic Combined Chemotherapy Protocols; Cross-Over Studies; Cytarabine;

2016
Accelerated intermittent theta burst stimulation treatment in medication-resistant major depression: A fast road to remission?
    Journal of affective disorders, 2016, Volume: 200

    Topics: Adult; Age Factors; Antineoplastic Combined Chemotherapy Protocols; Cross-Over Studies; Cytarabine;

2016
Accelerated intermittent theta burst stimulation treatment in medication-resistant major depression: A fast road to remission?
    Journal of affective disorders, 2016, Volume: 200

    Topics: Adult; Age Factors; Antineoplastic Combined Chemotherapy Protocols; Cross-Over Studies; Cytarabine;

2016
Accelerated intermittent theta burst stimulation treatment in medication-resistant major depression: A fast road to remission?
    Journal of affective disorders, 2016, Volume: 200

    Topics: Adult; Age Factors; Antineoplastic Combined Chemotherapy Protocols; Cross-Over Studies; Cytarabine;

2016
Accelerated intermittent theta burst stimulation treatment in medication-resistant major depression: A fast road to remission?
    Journal of affective disorders, 2016, Volume: 200

    Topics: Adult; Age Factors; Antineoplastic Combined Chemotherapy Protocols; Cross-Over Studies; Cytarabine;

2016
Accelerated intermittent theta burst stimulation treatment in medication-resistant major depression: A fast road to remission?
    Journal of affective disorders, 2016, Volume: 200

    Topics: Adult; Age Factors; Antineoplastic Combined Chemotherapy Protocols; Cross-Over Studies; Cytarabine;

2016
Accelerated intermittent theta burst stimulation treatment in medication-resistant major depression: A fast road to remission?
    Journal of affective disorders, 2016, Volume: 200

    Topics: Adult; Age Factors; Antineoplastic Combined Chemotherapy Protocols; Cross-Over Studies; Cytarabine;

2016
Accelerated intermittent theta burst stimulation treatment in medication-resistant major depression: A fast road to remission?
    Journal of affective disorders, 2016, Volume: 200

    Topics: Adult; Age Factors; Antineoplastic Combined Chemotherapy Protocols; Cross-Over Studies; Cytarabine;

2016
Accelerated intermittent theta burst stimulation treatment in medication-resistant major depression: A fast road to remission?
    Journal of affective disorders, 2016, Volume: 200

    Topics: Adult; Age Factors; Antineoplastic Combined Chemotherapy Protocols; Cross-Over Studies; Cytarabine;

2016